A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial.

Pasquier, David; Nickers, Philippe; Peiffert, Didier; Maingon, Philippe; Pommier, Pascal; Lacornerie, Thomas; Tresch, Emmanuelle; Barthoulot, Maël; Lartigau, Eric

Pasquier, David; Nickers, Philippe; Peiffert, Didier; Maingon, Philippe; Pommier, Pascal; Lacornerie, Thomas; Tresch, Emmanuelle; Barthoulot, Maël; Lartigau, Eric.

Afiliação

Pasquier D; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.
Nickers P; Univ. Lille, &, CNRS, Centrale Lille, UMR 9189 - CRIStAL, Lille, France.
Peiffert D; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.
Maingon P; Institut de Cancérologie de Lorraine-Alexis Vautrin, Nancy, France.
Pommier P; GHU La Pitié Salpêtrière, Sorbonne Université, Paris, France.
Lacornerie T; Department of Radiation Oncology, Centre Leon Berard, Lyon, France.
Tresch E; Medical Physics, Centre Oscar Lambret, Lille, France.
Barthoulot M; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Lartigau E; Department of Biostatistics, Centre Oscar Lambret, Lille, France.

Eur Urol Open Sci ; 54: 80-87, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37545850

Palavras-chave

Intermediate-risk prostate cancer; Prostate cancer; Stereotactic body radiotherapy; Stereotactic body radiotherapy boost

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Eur Urol Open Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google